Abeona Therapeutics, Inc. (ABEO)
5.355
-0.10
(-1.74%)
USD |
NASDAQ |
Jun 10, 16:00
5.355
0.00 (0.00%)
After-Hours: 18:44
Abeona Therapeutics Enterprise Value : 164.82M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 164.82M |
| June 08, 2026 | 160.84M |
| June 05, 2026 | 165.39M |
| June 04, 2026 | 185.86M |
| June 03, 2026 | 177.33M |
| June 02, 2026 | 178.47M |
| June 01, 2026 | 175.06M |
| May 29, 2026 | 183.59M |
| May 28, 2026 | 183.59M |
| May 27, 2026 | 178.47M |
| May 26, 2026 | 167.10M |
| May 22, 2026 | 164.26M |
| May 21, 2026 | 168.80M |
| May 20, 2026 | 157.43M |
| May 19, 2026 | 146.06M |
| May 18, 2026 | 160.27M |
| May 15, 2026 | 167.10M |
| May 14, 2026 | 173.35M |
| May 13, 2026 | 179.61M |
| May 12, 2026 | 177.90M |
| May 11, 2026 | 188.14M |
| May 08, 2026 | 190.41M |
| May 07, 2026 | 183.02M |
| May 06, 2026 | 196.67M |
| May 05, 2026 | 186.43M |
| Date | Value |
|---|---|
| May 04, 2026 | 193.26M |
| May 01, 2026 | 163.69M |
| April 30, 2026 | 165.39M |
| April 29, 2026 | 158.57M |
| April 28, 2026 | 159.71M |
| April 27, 2026 | 158.57M |
| April 24, 2026 | 161.41M |
| April 23, 2026 | 168.80M |
| April 22, 2026 | 175.06M |
| April 21, 2026 | 160.84M |
| April 20, 2026 | 166.53M |
| April 17, 2026 | 167.67M |
| April 16, 2026 | 160.84M |
| April 15, 2026 | 161.98M |
| April 14, 2026 | 150.04M |
| April 13, 2026 | 142.65M |
| April 10, 2026 | 134.12M |
| April 09, 2026 | 146.06M |
| April 08, 2026 | 131.84M |
| April 07, 2026 | 128.43M |
| April 06, 2026 | 125.59M |
| April 02, 2026 | 129.00M |
| April 01, 2026 | 115.35M |
| March 31, 2026 | 109.66M |
| March 30, 2026 | 66.40M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Corcept Therapeutics, Inc. | 7.988B |
| Forum Markets, Inc. | 67.23M |
| Precigen, Inc. | 1.362B |
| PDS Biotechnology Corp. | 51.69M |
| ACADIA Pharmaceuticals, Inc. | 2.936B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.08M |
| Revenue (Quarterly) | 8.72M |
| Total Expenses (Quarterly) | 25.80M |
| EPS Diluted (Quarterly) | -0.3016 |
| Gross Profit Margin (Quarterly) | 59.12% |
| Profit Margin (Quarterly) | -195.8% |
| Earnings Yield | 17.50% |
| Normalized Earnings Yield | 16.29 |